Long-term outcomes of pexidartinib in tenosynovial giant cell tumors

MLA

Zev A. Wainberg, et al. Long-Term Outcomes of Pexidartinib in Tenosynovial Giant Cell Tumors. Nov. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3b7e62c6514c565b67845cb9fbc56278&authtype=sso&custid=ns315887.

APA

Zev A. Wainberg, Jayesh Desai, John H. Healey, Emanuela Palmerini, Henry H. Hsu, Andrew J. Wagner, Qiang Wang, Michiel A. J. van de Sande, Dale Shuster, Anna Maria Frezza, William D. Tap, Charles Peterfy, Nicholas M. Bernthal, Silvia Stacchiotti, Eric L. Staals, & Hans Gelderblom. (2020). Long-term outcomes of pexidartinib in tenosynovial giant cell tumors.

Chicago

Zev A. Wainberg, Jayesh Desai, John H. Healey, Emanuela Palmerini, Henry H. Hsu, Andrew J. Wagner, Qiang Wang, et al. 2020. “Long-Term Outcomes of Pexidartinib in Tenosynovial Giant Cell Tumors,” November. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3b7e62c6514c565b67845cb9fbc56278&authtype=sso&custid=ns315887.